MALAT1 and non-small cell lung carcinoma: MALAT1 and thymosin β4 expression levels were identified as prognostic parameters for patient survival in stage I NSCLC that are at high risk to develop metastasis (p = 0.04 and p = 0.01, respectively) (143).